Indian Immunologicals

Indian Immunologicals to invest Rs 700 crore in Hyderabad for new animal vaccine facility

Read more

Indian Immunologicals announces its foray into Aquaculture health market

Read more

Indian Immunologicals to expand operations in New Zealand

Read more

Indian Immunologicals produces Covaxin drug substance

Read more

IIL to produce drug substance for Covaxin from June

Read more

PSUs roped in to ramp up COVID-19 vaccine production

Read more

IIL to invest Rs 75 cr for viral antigen manufacturing facility in Telangana

Read more

Why COVID-19 presents a golden opportunity to Indian pharma firms

Read more

Seven Indian pharmaceutical companies race to develop vaccine for deadly coronavirus

Read more

How glass vial makers are girding to boost access to COVID-19 vaccine

Read more